RANFUZOSIN MODIFIED RELEASE TABLETS 10MG
Product details
Registration number: SIN13984P
Classification: Prescription Only
Active ingredients: ALFUZOSIN HYDROCHLORIDE
Strength: 10mg
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Registrant: RANBAXY (MALAYSIA) SDN. BHD.
ATC code: G04CA01
HSA approval date: 5 July 2011
Manufacturer(s): SUN PHARMACEUTICAL INDUSTRIES LIMITED
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for RANFUZOSIN MODIFIED RELEASE TABLETS 10MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13984P
Classification: Prescription Only
What active ingredients and strength are recorded for RANFUZOSIN MODIFIED RELEASE TABLETS 10MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: ALFUZOSIN HYDROCHLORIDE
Strength: 10mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for RANFUZOSIN MODIFIED RELEASE TABLETS 10MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Who is the recorded registrant for RANFUZOSIN MODIFIED RELEASE TABLETS 10MG?
According to the HSA dataset updated 7 August 2026:
Registrant: RANBAXY (MALAYSIA) SDN. BHD.
Which manufacturers and countries are listed for RANFUZOSIN MODIFIED RELEASE TABLETS 10MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): SUN PHARMACEUTICAL INDUSTRIES LIMITED
Manufacturing country/countries: INDIA
Where can I look up RANFUZOSIN MODIFIED RELEASE TABLETS 10MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13984P or the exact product name RANFUZOSIN MODIFIED RELEASE TABLETS 10MG. The general register link does not preselect this product.
What are the source dates for this RANFUZOSIN MODIFIED RELEASE TABLETS 10MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this RANFUZOSIN MODIFIED RELEASE TABLETS 10MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13984P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)